Delivery Order SPE2DR25D1053-SPE2DR26FT246
- Not listed
- The Defense Logistics Agency awarded a $2,984.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units of issue, with an ultimate completion date of September 3, 2025. This non-set-aside contract represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving the...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Emverm 100 mg tablet chewables in unit dose packaging. This is a firm fixed price delivery order with a ceiling value of $16,635.72 and an ultimate completion date of August 15, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $8,427.06 to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units under a firm fixed price contract type. This non-set-aside award was issued on August 8, 2025, with an ultimate completion date of August 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a prime contractor for the DLA and is a major pharmaceutical distributor specializing in medical supply chain support for federal...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $1,998.57 to AmerisourceBergen Drug Corp for the supply of Emverm 100 mg tablet chewable units, with a completion date of September 29, 2025. This non-set-aside award was issued on September 26, 2025, with performance to be fulfilled at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has been selected as...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $36,326.13 delivery order to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units of issue on September 16, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under...
- The Defense Logistics Agency awarded a $39,912.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units on September 12, 2025, with completion targeted for September 15, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $11,190.41 to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed price, competitively awarded delivery order represents a single-item pharmaceutical procurement with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $19,065.20 to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units. This non-competitive, firm fixed-price delivery order was issued on July 21, 2025, with an ultimate completion date of July 22, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewables valued at $10,005.69 with an ultimate completion date of April 28, 2025. This is a firm fixed price, non-competitive delivery order with no set-aside designation, issued under AmerisourceBergen's existing indefinite delivery contract vehicle with DLA. The contractor will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Emverm 100 mg tablet chewable units of issue, valued at $11,816.54 under a firm fixed price arrangement. The contract, awarded on September 24, 2025, with an ultimate completion date of September 25, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT246Delivery Order
The Defense Logistics Agency awarded a $16,074.31 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units of issue on October 23, 2025, with an ultimate completion date of October 24, 2025. This non-set-aside award represents a single delivery order issued under the company's larger indefinite delivery contract vehicle with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor supplying a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. This delivery order falls under AmerisourceBergen Drug Corp's existing SPE2DX indefinite delivery contract with DLA valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive pharmaceutical support vehicle for global military healthcare programs. The company's substantial IDC portfolio with DLA Troop Support enables it to supply specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains. The contract was competitively awarded and reflects the company's demonstrated capability to meet federal medical procurement requirements for agencies including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.1k | 10/23/25 |